Veterinary Medicines

FEBRIVAC 3-PLUS

Authorised
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 5 ANTIGENS
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 6 ANTIGENS
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 7,8 ANTIGENS
  • Clostridium botulinum, type C, toxoid
  • Mink enteritis virus, Inactivated
Download as PDF

Product identification

Medicine name:
FEBRIVAC 3-PLUS
Active substance:
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 5 ANTIGENS
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 6 ANTIGENS
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 7,8 ANTIGENS
  • Clostridium botulinum, type C, toxoid
  • Mink enteritis virus, Inactivated
Target species:
  • Mink
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 5 ANTIGENS
    100.00
    million cells
    /
    1.00
    millilitre(s)
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 6 ANTIGENS
    100.00
    million cells
    /
    1.00
    millilitre(s)
  • PSEUDOMONAS AERUGINOSA IMMUNOTYPE 7,8 ANTIGENS
    100.00
    million cells
    /
    1.00
    millilitre(s)
  • Clostridium botulinum, type C, toxoid
    0.50
    relative potency
    /
    1.00
    millilitre(s)
  • Mink enteritis virus, Inactivated
    4.00
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Mink
      • Unspecified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI20CL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."